Latest news and press releases about Solana Company (HSDT): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma.
Price
| Price | $2.29 |
| Market Cap | $134M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.09 |
| EV / EBITDA | -0.97 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -122.85% |
| Return on Invested Capital | -13.92% |
| Return on Assets | -89.33% |
| Gross Margin | 95.53% |
| Operating Margin | -200.47% |
| Net Margin | -1302.78% |
Related companies: CATX · ELMD · INFU · INGN · NNOX · OM · PROF
Explore sector: Financial Services · Asset Management
More sections of HSDT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks